Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rap guanine nucleotide exchange factor 5 (RAPGEF5) is a member of the guanine nucleotide exchange factor (GEF) family that specifically functions as an activator for Rap1A, Rap2A, and MRAS/M-Ras GTPases[1][3]. It promotes the switch from inactive GDP-bound to active GTP-bound states, thereby facilitating signal transduction crucial for diverse biological processes including cell adhesion, migration, development, and the nuclear transport of β-catenin—a key effector in Wnt signaling[2][3]. RAPGEF5 is implicated in left-right patterning during embryogenesis and congenital heart disease[2][3]. It does not presently have known pharmacological antagonists or agonists but represents a potential target in cardiac, developmental, and oncogenic signaling pathways[2][3].
Drugs targeting RAPGEF5 (hypothetically) would inhibit or enhance its GEF activity, modulating signal transduction by affecting GTP-bound states of Rap1A, Rap2A, MRAS (M-Ras), and β-catenin nuclear translocation[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rap guanine nucleotide exchange factor 5 (RAPGEF5).